Seeking Alpha

Covidien (COV) announces it purchased privately-held Barrx Medical in a $325M deal expected to...

Covidien (COV) announces it purchased privately-held Barrx Medical in a $325M deal expected to close in Q1. The firm says the acquisition will help expand its ability to treat gastrointestinal diseases, such as Barrett’s esophagus.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)